Piramal Life Sciences
BSE: 532979 | NSE: PIRLIFE | ISIN: INE122J01015 | Pharmaceuticals
 |
Nine Months of Piramal Life Sciences |
------------------- in Rs. Cr. ------------------- |
| ||||||
|
||||||
| Dec '08 | ||||||
|
||||||
| Sales Turnover | 1.77 | |||||
| Other Income | -- | |||||
| Total Income | 1.77 | |||||
| Total Expenses | 62.42 | |||||
| Operating Profit | -60.65 | |||||
| Profit On Sale Of Assets | -- | |||||
| Profit On Sale Of Investments | -- | |||||
| Gain/Loss On Foreign Exchange | -- | |||||
| VRS Adjustment | -- | |||||
| Other Extraordinary Income/Expenses | -- | |||||
| Total Extraordinary Income/Expenses | -- | |||||
| Tax On Extraordinary Items | -- | |||||
| Net Extra Ordinary Income/Expenses | -- | |||||
| Gross Profit | -60.65 | |||||
| Interest | 5.28 | |||||
| PBDT | -65.93 | |||||
| Depreciation | 7.30 | |||||
| Depreciation On Revaluation Of Assets | -- | |||||
| PBT | -73.23 | |||||
| Tax | 0.26 | |||||
| Net Profit | -73.49 | |||||
| Prior Years Income/Expenses | -- | |||||
| Depreciation for Previous Years Written Back/ Provided | -- | |||||
| Dividend | -- | |||||
| Dividend Tax | -- | |||||
| Dividend (%) | -- | |||||
| Earnings Per Share | -- | |||||
| Book Value | -- | |||||
| Equity | 25.45 | |||||
| Reserves | -- | |||||
| Face Value | 10.00 | |||||
| ||||||
| Source : Religare Technova | ||||||
| Explore Piramal Life connections | ||||||
| ||||||
